Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
NRx Pharmaceuticals | NRXP | Sep 19, 2024 | 1.64 | +1.23 |
NSTS Bancorp | NSTS | Sep 19, 2024 | 9.70 | 0.00 |
Nu Holdings | NU | Sep 19, 2024 | 14.80 | -0.34 |
Nu Skin Enterprises | NUS | Sep 19, 2024 | 7.16 | -2.19 |
Nuburu | BURU | Sep 19, 2024 | 0.43 | +0.42 |
NuCana ADR | NCNA | Sep 19, 2024 | 3.26 | -5.23 |
Nucor | NUE | Sep 19, 2024 | 149.00 | +4.21 |
Nukkleus | NUKK | Sep 19, 2024 | 0.21 | +11.70 |
Nurix Therapeutics | NRIX | Sep 19, 2024 | 25.06 | +1.29 |
NuScale Power | SMR | Sep 19, 2024 | 9.61 | +4.80 |
Nustar Energy C Pref | NS-C | Sep 19, 2024 | 24.99 | 0.00 |
Nutanix A | NTNX | Sep 19, 2024 | 58.99 | +2.77 |
Nutex Health | NUTX | Sep 19, 2024 | 25.17 | +1.25 |
Nutriband | NTRB | Sep 19, 2024 | 5.60 | +10.24 |
Nutrien | NTR | Sep 19, 2024 | 47.90 | +2.31 |
Nuvalent A | NUVL | Sep 19, 2024 | 103.25 | +0.60 |
Nuvation Bio A | NUVB | Sep 19, 2024 | 2.95 | +1.72 |
Nuvectis Pharma | NVCT | Sep 19, 2024 | 6.75 | +0.75 |
Nuveen Amtfree Municipal Credit Income Fund | NVG | Sep 19, 2024 | 13.30 | +0.15 |
Nuveen Amtfree Municipal Value Fund | NUW | Sep 19, 2024 | 14.28 | +0.14 |
Nuveen Amtfree Quality Municipal Income Fund | NEA | Sep 19, 2024 | 11.86 | +0.34 |
Nuveen Arizona Quality Municipal Fund | NAZ | Sep 19, 2024 | 11.72 | -0.17 |
Nuveen California Amtfree Quality Municipal Income Fund | NKX | Sep 19, 2024 | 13.88 | -0.07 |
Nuveen California Municipal Value Fund | NCA | Sep 19, 2024 | 9.12 | -0.22 |
Nuveen California Quality Municipal Income Fund | NAC | Sep 19, 2024 | 11.97 | +0.25 |
Nuveen California Select Taxfree Income Portfolio | NXC | Sep 19, 2024 | 14.07 | +0.79 |
Nuveen Churchill Direct Lending | NCDL | Sep 19, 2024 | 17.89 | -0.17 |
Nuveen Core Equity Alpha Fund | JCE | Sep 19, 2024 | 15.14 | +0.46 |
Nuveen Core Plus Impact Fund | NPCT | Sep 19, 2024 | 11.59 | -0.77 |
Nuveen Credit Strategies Income Fund Shares Of Beneficial In | JQC | Sep 19, 2024 | 5.67 | -0.53 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.